Nurse Practitioner, Family · Joplin, MO
NPI
1700242005
Since 2016
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
100 Mercy Way, Suite 580
Joplin, MO, 64804
Phone (417) 556-8555
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
1,122 services
Medicare patients, 2024
253
Average age 70
Drug cost, 2024
$3.2M
5,529 prescriptions
Company payments, 2025
$1,816
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amanda L Hunter was code 99214 (office e&m - established), 347 times for 221 patients. In total Amanda L Hunter billed 1,122 services in 14 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-02-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 347 | 221 | $69.75 | $24K |
| 83036 Blood Count | Office | 213 | 152 | $9.47 | $2,018 |
| 95251 Test - Miscellaneous | Office | 188 | 112 | $20.93 | $3,935 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 185 | 138 | $9.48 | $1,753 |
| 99215 Office E&M - Established | Office | 32 | 30 | $105.48 | $3,375 |
| 99204 Office E&M - New | Office | 16 | 16 | $77.38 | $1,238 |
By year: 2022 $45K for 1,105 services; 2023 $42K for 995 services; 2024 $40K for 1,122 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 213 | 152 | $9.47 | $2,018 |
Medicare prescription drug claims, 2024
In 2024, the drug Amanda L Hunter prescribed most often to Medicare patients was Ozempic (Semaglutide), with 459 prescriptions and refills. In total Amanda L Hunter wrote 5,529 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 459 | 672 | 89 | $648K |
| Atorvastatin Calcium Generic | 371 | 891 | 96 | $2,610 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 305 | 536 | 68 | $338K |
| Levothyroxine Sodium Generic | 305 | 691 | 82 | $2,100 |
| Metformin Hcl Er Metformin Hcl | 261 | 676 | 85 | $1,850 |
| Mounjaro Tirzepatide | 228 | 266 | 46 | $284K |
| Tresiba Flextouch U-200 Insulin Degludec | 174 | 285 | 42 | $178K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 158 | 292 | 34 | $173K |
| Gabapentin Generic | 144 | 216 | 28 | $3,809 |
| Tresiba Flextouch U-100 Insulin Degludec | 137 | 259 | 41 | $79K |
| Fiasp Flextouch Insulin Aspart (Niacinamide) | 131 | 182 | 42 | $124K |
| Jardiance Empagliflozin | 130 | 233 | 35 | $139K |
| Rosuvastatin Calcium Generic | 128 | 317 | 37 | $1,392 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 121 | 249 | 46 | $11K |
| Metformin Hcl Generic | 118 | 295 | 37 | $627 |
Brand drugs: 3,334 claims; generic drugs: 1,732 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amanda L Hunter $1,816 ($1,816 in general payments such as food, travel and fees) from 21 companies. The largest payer was Novo Nordisk Inc with $417.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 23 | $417 |
| Dexcom, Inc. DXCM | 21 | $266 |
| Abbott Laboratories ABT | 10 | $190 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $181 |
| Amgen Inc. AMGN | 5 | $94.03 |
| Sanofi-Aventis U.S. LLC SNY | 5 | $90.41 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $77.17 |
| Radius Health, Inc. | 3 | $71.81 |
| Ascendis Pharma Endocrinology Inc ASND | 3 | $61.14 |
| Lilly USA, LLC LLY | 3 | $56.77 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.